Danaher Corp (NYSE:DHR)

248.34
BATS BZX Real-Time Price
As of 11:16am ET
 -3.70 / -1.47%
Today’s Change
221.22
Today|||52-Week Range
283.63
-6.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$183.4B

Company Description

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Contact Information

Danaher Corp.
2200 Pennsylvania Avenue North West
Washington District Of Columbia 20037-1701
P:(202) 828-0850
Investor Relations:

Employees

Shareholders

Mutual fund holders46.69%
Other institutional34.03%
Individual stakeholders16.26%

Top Executives

Rainer M. BlairPresident, Chief Executive Officer & Director
Matthew R. McGrewChief Financial Officer & Executive Vice President
Jose-Carlos Gutiérrez-RamosChief Science Officer & Senior Vice President
Sadik KassimChief Technology Officer
Brian W. EllisSenior Vice President & General Counsel